Results 1 to 10 of about 204,941 (177)
IEEE Transactions on Audio, Speech, and Language Processing, 2013 In this paper a new adaptive audio watermarking algorithm based on Empirical Mode Decomposition (EMD) is introduced. The audio signal is divided into frames and each one is decomposed adaptively, by EMD, into intrinsic oscillatory components called ...
BOUDRAA, Abdel-Ouahab, KHALDI, Kais
core +8 more sources
A Modified Noise-Resistant Trend Estimation Method Based on EMD and SSA for Aeroelastic Aircraft Systems [PDF]
AUT Journal of Modeling and Simulation, 2021 Aimed at the nonlinear system identification of aeroelastic aircraft, the signal decomposition methods are required to extract the contributing natural and non-standard flight modes from flight test data, especially in the presence of flight noise.
Seyed Amin Bagherzadeh +1 more
doaj +1 more source
OncoImmunology, 2021 Avelumab is an IgG1 anti–programmed death ligand 1 (anti–PD-L1) monoclonal antibody that has been approved as a monotherapy for metastatic Merkel cell carcinoma and advanced urothelial carcinoma, and in combination with axitinib for advanced renal cell ...
Hulin Jin +12 more
doaj +1 more source
Frontiers in Immunology, 2023 Autoimmune diseases vary in the magnitude and diversity of autoantibody profiles, and these differences may be a consequence of different types of breaks in tolerance.
Thomas Clarke +15 more
doaj +1 more source
Clinical and Translational Science, 2022 Bintrafusp alfa, a first‐in‐class bifunctional fusion protein composed of the extracellular domain of TGF‐βRII (a TGF‐β “trap”) fused to a human IgG1 mAb blocking PD‐L1, is being evaluated for efficacy and safety in solid tumor indications as monotherapy
Yulia Vugmeyster +5 more
doaj +1 more source
Bispecific antibodies: A guide to model informed drug discovery and development
Heliyon, 2021 Affinity (KD) optimization of monoclonal antibodies is one of the factors that impacts the stoichiometric binding and the corresponding efficacy of a drug.
Irina Kareva +3 more
doaj +1 more source
ACR Open Rheumatology, 2023 Objective To use cell‐based gene signatures to identify patients with systemic lupus erythematous (SLE) in the phase II/III APRIL–SLE and phase IIb ADDRESS II trials most likely to respond to atacicept.
Matthew Studham +10 more
doaj +1 more source
Translational Oncology, 2022 Combinatorial immunotherapy approaches are emerging as viable cancer therapeutic strategies for improving patient responses and outcomes. This study investigated whether two such immunotherapies, with complementary mechanisms of action, could enhance ...
Chunxiao Xu +8 more
doaj +1 more source
Scientific Reports, 2023 TL-895 (formerly known as M7583) is a potent, highly selective, adenosine triphosphate (ATP)-competitive, second-generation, irreversible inhibitor of Bruton’s tyrosine kinase (BTK).
Samantha M. Goodstal +13 more
doaj +1 more source
Membranes, 2023 Bubble point tests are widely used for assessing the integrity of sterilizing-grade membrane cartridge filters. While many authors have considered the limitations of bubble point tests as applied to cartridge filters, the level of bacterial retention ...
Sal Giglia +2 more
doaj +1 more source